Talphera (TLPH) Long-Term Deferred Tax (2017 - 2018)

Talphera (TLPH) posted Long-Term Deferred Tax of $351000.0 for Q3 2018, little changed on a QoQ basis from $351000.0 in Q2 2018.

Analysis

Talphera (TLPH) Long-Term Deferred Tax (2017 - 2018) Analysis & Trends

Talphera has reported Long-Term Deferred Tax for 2 years, with the latest figure at $351000.0 in Q3 2018.

On a quarterly basis, Long-Term Deferred Tax changed N/A year-over-year to $351000.0 in Q3 2018; TTM through Sep 2018 was $351000.0, a N/A change from a year earlier, with the FY2017 full-year figure at $703000.0, changed N/A from the prior year.
Long-Term Deferred Tax was $351000.0 for Q3 2018 at Talphera, roughly flat from $351000.0 in the prior quarter.
The five-year high for Long-Term Deferred Tax was $703000.0 in Q4 2017, with the low at $351000.0 in Q2 2018.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Amgen	206.44 Bn	192.45 Bn	7.24 Bn
2	Gilead Sciences	179.97 Bn	176.79 Bn	6.22 Bn
3	Vertex Pharmaceuticals	130.57 Bn	122.72 Bn	2.84 Bn
4	Regeneron Pharmaceuticals	81.63 Bn	73.63 Bn	3.93 Bn
5	Argenx Se	60.34 Bn	55.16 Bn	1.37 Bn
6	Moderna	54.37 Bn	49.23 Bn	52.00 Mn
7	Alnylam Pharmaceuticals	33.07 Bn	29.76 Bn	992.69 Mn
8	Biogen	31.84 Bn	30.55 Bn	1.96 Bn
9	Roivant Sciences	29.49 Bn	29.49 Bn	1.16 Mn
10	Talphera	92.90 Mn	92.90 Mn	-

Historic Data

Download Data